PD51-09 THE VALUE OF RE-STAGING BY COMPUTED-TOMOGRAPHY (CT) TO MONITOR THE RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN MUSCLE-INVASIVE BLADDER CANCER. A LONGITUDINAL LONG-TERM SINGLE CENTER STUDY

Volume: 206, Issue: Supplement 3
Published: Sep 1, 2021
Abstract
You have accessJournal of UrologyBladder Cancer: Invasive III (PD51)1 Sep 2021PD51-09 THE VALUE OF RE-STAGING BY COMPUTED-TOMOGRAPHY (CT) TO MONITOR THE RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN MUSCLE-INVASIVE BLADDER CANCER. A LONGITUDINAL LONG-TERM SINGLE CENTER STUDY Bernhard Kiss, Sandro Lütolf, Marc A. Furrer, Nathan Papa, Beat Roth, Marcus Cumberbatch, Mihai Dorin Vartolomei, Benjamin C. Thomas, Harriet C. Thoeny, Roland Seiler-Blarer, and...
Paper Details
Title
PD51-09 THE VALUE OF RE-STAGING BY COMPUTED-TOMOGRAPHY (CT) TO MONITOR THE RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN MUSCLE-INVASIVE BLADDER CANCER. A LONGITUDINAL LONG-TERM SINGLE CENTER STUDY
Published Date
Sep 1, 2021
Volume
206
Issue
Supplement 3
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.